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Abstract
Introduction: Inflammatory myofibroblastic tumor is a very rare benign tumor in children that mimics malignant
tumors in its aggressiveness locally and by the possibility of recurrence after surgical resection, and causing anemia
of chronic disease, which is a decrease in hemoglobin 1 to 2 g/dL below normal level in a patient with chronic
illness.
Case presentation: A 32-month-old boy from Libya presented with microcytic hypochromic anemia. He had been
treated in three countries and five centers without response to medical therapy. He was investigated at our center
and found to have a mass in the colon causing intermittent intussusception and bleeding. He was treated
surgically, and his condition improved dramatically. The pathology report proved a diagnosis of inflammatory
myofibroblastic tumor.
Conclusion: We report a case of an unusual tumor of the gastrointestinal tract causing chronic anemia not
responding to medical treatment, and discuss the characteristics of inflammatory myofibroblastic tumor. In our
case, we stress the involvement of a multidisciplinary team in treating such a patient who presents with common
symptoms and signs but in whom there has been no response to any of the measures and treatment protocols.
Introduction
Anemia of chronic disease is an entity that explains a
decrease in hemoglobin, usually 1 to 2 g/dL below nor-
mal level in a patient with a chronic illness. This form
of anemia is multifactorial and can be caused by auto-
immune diseases, chronic infections or neoplasms. Ery-
throcytes are usually normocytic but can be microcytic,
in which case distinguishing it from iron-deficiency ane-
mia can be challenging. When anemia of chronic disease
is suspected, a systematic approach to explore possible
causes should be used to avoid unnecessary investiga-
tions and to establish the diagnosis.
Inflammatory myofibroblastic tumor (IMT) is a very
rare benign tumor that mimics malignant tumors in its
aggressiveness locally and by the possibility of recur-
rence after surgical resection. Grossly, the tumor is a
solid, well-circumscribed, nonencapsulated mass that
could be found in many anatomic locations, including
the colon, lung, bladder, spleen, breast, pancreas, liver,
spermatic cord, prostate, peripheral nerves, soft tissue
and orbit. The whole mark of these tumors is the spin-
dle cell proliferation, which are in fact myofibroblasts,
associated with a variable inflammatory component and
thence the name [1]. Herein we report a case of IMT
that arises from the transverse colon causing colocolic
intussusception, and we discuss the importance of a
multidisciplinary approach to reach a diagnosis in such
cases.
Case presentation
A 32-month-old boy from Libya presented with a pic-
ture of microcytic hypochromic anemia. He was pre-
viously healthy until the age of 16 months, when he was
found to have pallor, loss of appetite and hypoactivity.
The patient was diagnosed with iron-deficiency anemia
(hemoglobin, 7 mg/dL) and started on iron supplements
with no response to treatment. He underwent extensive
investigations in six different institutions and three dif-
ferent countries. He received five blood transfusions and
was kept on oral ferrous sulphate. * Correspondence: mmasarweh@khcc.jo
1Department of Surgery, King Hussein Cancer Center, Amman, Jordan
Full list of author information is available at the end of the article
Salameh et al. Journal of Medical Case Reports 2011, 5:69
http://www.jmedicalcasereports.com/content/5/1/69 JOURNAL OF MEDICAL
CASE REPORTS
© 2011 Salameh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The patient was started on a gluten-free diet on the
assumption of celiac disease, but blood test and endo-
scopic biopsy results of the upper gastrointestinal (GI)
tract were normal. He was also treated with metronida-
zole because of amoebic cysts in the stool. Two weeks
before referral, the patient was diagnosed with Coomb’s
negative autoimmune hemolytic anemia and was started
on prednisone (2 mg/kg/day) with a dramatic response
as his hemoglobin increased from 7.0 g/dL to 9.3 g/dL
and reticulocytes increased from 1% to 9%. At our insti-
tution, the patient’s history and medical record were
thoroughly reviewed. He had a history of intermittent
abdominal pain associated with chronic constipation
treated with laxatives. There were episodes of mucus in
the stool associated with streaks of blood. On examina-
tion, the child was irritable with facial swelling and
abdominal distension. He looked pale with no jaundice.
He had clubbing of the fingers. He had normal air
entry. Heart auscultation revealed a soft systolic mur-
mur. He had no lymphadenopathy and no hepatospleno-
megaly. There were no abdominal masses appreciated
on the first visit, but on a later visit, a left side and
suprapubic mass was felt, and a hydrocele was found
upon scrotal examination. During this time, prednisone
was tapered and stopped.
Lower GI endoscopy was performed on the assump-
tion of inflammatory bowel disease; the mucosa of the
rectum and sigmoid were normal, but there was a mass
in the sigmoid covered by a layer of exudate, and the
scope could not go beyond this mass (Figure 1). Lower
GI contrast study was carried out to delineate the proxi-
mal colon, but the picture was suggestive of
intussusception.
A computed tomography scan of the abdomen showed
a mass in the left side of the abdomen with suspicion of
intussusception. Ultrasonography was not helpful in
identifying the nature of that mass. Laparotomy was
d o n ea n ds h o w e dt h a tt h e r ew a sa ni n t r a l u m i n a lm a s s
reaching the sigmoid colon originating from the mid
transverse colon, causing colocolic intussusception
(Figure 2). Resection of the involved segment of the
colon was done with end-to-end anastomosis. The
patient had a smooth postoperative course, and his
hemoglobin level improved dramatically and quickly
during the first week after surgery. The histopathology
showed extensive surface ulceration and was character-
ized by a proliferation of plump polygonal or more spin-
dle-shaped cells with amphophilic cytoplasm and
vesicular nuclei with prominent nucleoli. The lesion
cells were distributed in a patternless fashion within a
loose myxoid matrix, which contained numerous thin-
walled blood vessels and prominent mixed inflammatory
cells, including numerous plasma cells and lymphocytes.
Immunostains showed positivity for S100, keratin
AE1/AE3, and more focally for desmin. Smooth muscle
actin and anaplastic lymphoma kinase 1 were negative.
Discussion
IMTs are benign solid tumors that arise in many ana-
tomic sites. The lung is the most common site, but
other sites are also reported, including the small and
large bowel mesentery, mediastinum, retroperitoneum,
omentum, spleen, spermatic cord, prostate, peripheral
nerves, soft tissue, orbit and diaphragm [1-3]. IMT is
considered a benign tumor with local aggressive course
but is not a malignancy in itself.
The presentation of IMT varies depending on the site
and includes fever, weakness, abdominal pain, upper GI
bleeding, weight loss, vomiting, poor appetite, gastroeso-
phageal reflux, pallor, growth retardation and ascites.
These symptoms can appear either alone or in a combi-
nation [4]. Laboratory investigations are not specific.
The most common finding is microcytic hypochromic
anemia refractory to iron therapy (90.9%), but other
Figure 1 Colonoscopic view. Figure 2 Intraoperative view.
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tation rate, thrombocytosis, eosinophilia and hypergam-
maglobulinemia, may be seen [4,5].
Histopathologically, IMT is characterized by spindle-
shaped cells with chronic inflammatory cell infiltrate
consisting of plasma cells, lymphocytes and occasional
histiocytes [1,6]. These inflammatory cells are usually
scattered throughout the lesion to a variable degree [1].
Three different histologic patterns have been described.
In the first, myofibroblasts have a spindle appearance and
are distributed loosely in a myxoid stroma. The second is
more densely packed stromal cells intermingled with an
inflammatory component. The third is characterized by
hyalinized, hypocellular stroma. These three patterns can
be found in a single tumor intermixed closely [1]. All of
these features resolve after resection of the tumor [5].
Karnak et al. [5] reported a case with very high leukocyte
count and suggest that this could be a good marker for
recurrence. Differentiating IMT from sarcoma may be
challenging because of the local invasiveness of both
pathologies. The lack of mitosis and nuclear atypia in
IMT can differentiate it from sarcomas [7].
About 18% to 40% of IMTs recur, and most recur-
rences appear in extrapulmonary lesions that are larger
than 8 cm and are locally invasive [6,8]. Retroperitoneal
and mesenteric IMT seem to be associated with more
frequent recurrences [9]. Complete surgical resection is
the treatment of choice and should be advocated unless
prohibited [1,9].
Controversy still exists regarding the role of che-
motherapy in IMT patients. According to Kovach et al.
[1], chemotherapy has been reserved for patients for
whom resection is neither complete nor possible. The
dosage and regimen of chemotherapy should be adjusted
according to the biologic aggressiveness of the tumor,
and there is no good evidence to support chemotherapy
after complete resection regardless of tumor biology [1].
Radiation treatment showed some benefit in pulmonary
IMT [10]. On the other hand, failure of radiation ther-
apy in treating IMT has been reported, confirming sur-
gical excision to be the treatment of choice [11].
Radiation therapy is used in palliative treatment of this
tumor, decreasing the mass effect of IMT and in
patients whose tumors are not resectable [1]. The use of
steroids is also recommended to reduce the inflamma-
tory process that is surrounding the tumor, especially if
the tumor is in the central nervous system [1,12]. Using
nonsteroidal antiinflammatory drugs as a conservative
measure for treatment of patients with IMT whose
tumors are not amenable to surgical resection [13].
Conclusion
In our case, we stress on the involvement of multidisci-
plinary team in treating such a patient who presents
with common symptoms and signs but who has not
responded to the measures and treatment protocols; this
team should involve medical, surgical, radiology and
pathology personnel.
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